surmount-1 tirzepatide 15 mg weight loss percent Trial Tirzepatide (ZEPBOUND) Approved for Chronic

PLoS One 2015;10:e0139565.ArticlePubMedPMC 112

Precautions: Avoid alcohol and other CNS depressants May impair driving and concentration Do not stop abruptly (risk of withdrawal) Use cautiously in respiratory disease, head injury, and elderly patients

Suitable for both men and women under medical supervision, this therapy delivers noticeable results over a short treatment period and can be maintained with periodic follow-up sessions

In rare cases, switching to an oral formulation or exploring a different compound may improve your tolerability while maintaining weight loss efficacy

A few practical priorities often make the biggest difference: Protein: helps with fullness and supports muscle maintenance during weight loss Fibre: supports digestion and helps people feel satisfied for longer Added sugar: reducing it can make appetite and blood glucose easier to manage Meal regularity: consistent eating times can reduce reactive snacking This approach is flexible enough to work across different diets and preferences